KS900: A hypoxia-directed, reductively activated methylating antitumor prodrug that selectively ablates O6-alkylguanine-DNA alkyltransferase in neoplastic cells

Published 2011 View Full Article

Authors

Keywords

Journal

BIOCHEMICAL PHARMACOLOGY

Volume 81, Issue 10, Pages 1201-1210

Publisher

Elsevier BV

Online

2011-03-11

DOI

10.1016/j.bcp.2011.02.019

Ask authors/readers for more resources

Find the ideal target journal for your manuscript

Explore over 38,000 international journals covering a vast array of academic fields.

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started

BIOCHEMICAL PHARMACOLOGY

Ask authors/readers for more resources

Protocol

Reagent

Reprint

Find the ideal target journal for your manuscript

Become a Peeref-certified reviewer